Kidney Cancer
📧 Sign up to get email alerts when something new happens for Kidney Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
A completed study evaluating risk-based screening and prognostic factors for second primary malignancies in kidney cancer patients.
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
The LEARN trial by the University of Sydney is evaluating a new AI-based radiotherapy environment and is currently recruiting across several…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers
Clinical trial update on reconstituting a human immune system in a patient-derived xenograft model of genitourinary cancers; the study statu…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies [NA]
This clinical trial is evaluating whether preoperative oral immunomodulation can influence postoperative complications after cystectomy and …
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses [NA]
A UNC Lineberger Comprehensive Cancer Center-sponsored trial evaluating Genomic Risk Assessment and Decisional Evaluation for Small Renal Ma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) [Phase 1]
This document describes a Phase 1 dose-escalation trial of PT2385 in patients with advanced clear cell renal cell carcinoma (renal cell carc…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Safety and Performance Assessment of a First Four Arms on Demand Open Robotic Solution for Assisted PN, RN and RP [NA]
The update reports safety and performance data for Rob Surgical Systems' four-arm on-demand open robotic solution used during partial nephre…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)
The SABINA trial is evaluating stereotactic body radiotherapy for medically inoperable localized renal tumors. It is currently active but no…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
This clinical trial update describes a biobank and patient registry for aggressive tumors to support translational and analytical research; …
-
CLINICAL_TRIALS other · 2024-05-01Clinical Trial Update: The Man Van Project [NA]
The Man Van Project clinical trial, sponsored by Royal Marsden NHS Foundation Trust, is currently recruiting for prostate cancer and related…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy [Phase 3]
Phase 3 trial update evaluating nivolumab in patients with localized kidney cancer undergoing nephrectomy; status ACTIVE_NOT_RECRUITING with…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery [Phase 3]
A Phase 3 trial (S0931) evaluating everolimus as adjuvant therapy after kidney cancer surgery has completed, with results posted. The study …
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging [Phase 2]
Phase 2 trial evaluating contrast-enhanced ultrasound for subtyping and staging of kidney cancer; study completed with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery [Phase 4]
Phase 4 clinical trial evaluating perioperative intravenous lidocaine infusion in robotic-assisted urologic surgery has been terminated with…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating 3-AP for previously untreated locally recurrent or metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma [Phase 2]
Phase 2 clinical trial update evaluating radiation therapy for newly diagnosed brain metastases from kidney cancer, melanoma, or sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update for atrasentan in locally recurrent or metastatic kidney cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel and carboplatin for locally advanced or metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma [Phase 2]
Phase 2 trial investigating denosumab with pembrolizumab in clear cell renal cell carcinoma (metastatic).
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer [Phase 2]
Phase 2 study of the MET kinase inhibitor INC280 (epernestib) in papillary renal cell cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Tislelizumab Plus Lenvatinib in Stage III-IV RCC [Phase 2]
A Phase 2 trial updating tislelizumab plus lenvatinib in advanced kidney cancer is underway; results are currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 trial investigating dasatinib combined with ifosfamide, carboplatin, and etoposide in young patients with metastatic or recu…
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update evaluating tretinoin in combination with interferon alfa for metastatic kidney cancer has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC) [Phase 1, Phase 2]
Clinical trial update for QL1706 plus lenvatinib in advanced renal cell carcinoma (Phase 1/2) with unknown status.